Evidence map›Paper›PMID 31150464›Full record

ArticlePloS one2019

MLST typing of Treponema pallidum subsp. pallidum in the Czech Republic during 2004-2017: Clinical isolates belonged to 25 allelic profiles and harbored 8 novel allelic variants.

Eliška Vrbová, Linda Grillová, Lenka Mikalová, Petra Pospíšilová, Radim Strnadel, Eliška Dastychová, Martina Kojanová, Miluše Kreidlová, Daniela Vaňousová, Filip Rob and 8 more

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Molecular investigation ofMicrobiology spectrum · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Treponema pallidum SubspeciesMicrobiology spectrum · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Eliška VrbováDepartment of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Linda GrillováDepartment of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Lenka MikalováDepartment of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Petra PospíšilováDepartment of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Radim StrnadelDepartment of Dermatovenerology, Faculty Hospital Brno, Brno, Czech Republic.
Eliška DastychováDepartment of Medical Microbiology, Faculty of Medicine, St. Anne's Hospital and Masaryk University, Brno, Czech Republic.
Martina KojanováDepartment of Dermatology, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Miluše KreidlováInstitute of Medical Biochemistry and Laboratory Diagnostics of the General University Hospital, The First Faculty of Medicine of Charles University in Prague, Prague, Czech Republic.
Daniela VaňousováDepartment of Dermatovenerology, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Filip RobDepartment of Dermatovenerology, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Přemysl ProcházkaOutpatient STI Clinic Medicentrum, Prague, Czech Republic.
Alena KrchňákováDepartment of Medical Microbiology, Faculty of Medicine, St. Anne's Hospital and Masaryk University, Brno, Czech Republic.
Vladimír VaškůDepartment of Medical Microbiology, Faculty of Medicine, St. Anne's Hospital and Masaryk University, Brno, Czech Republic.
Vladana WoznicováDepartment of Medical Microbiology, Faculty of Medicine, St. Anne's Hospital and Masaryk University, Brno, Czech Republic.
Monika Dvořáková HeroldováDepartment of Medical Microbiology, Faculty of Medicine, St. Anne's Hospital and Masaryk University, Brno, Czech Republic.
Ivana KuklováDepartment of Dermatology, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Hana ZákouckáNational Reference Laboratory for Diagnostics of the Syphilis, National Institute for Public Health, Prague, Czech Republic.
David ŠmajsDepartment of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A recently introduced Multilocus Sequence Typing scheme for Treponema pallidum subsp. pallidum was applied to clinical samples collected from 2004 to 2017 from the two largest cities (Prague and Brno) in the Czech Republic. Altogether, a total of 675 samples were tested in this study and 281 of them were found PCR-positive for treponemal DNA and typeable. Most of the typed samples (n = 281) were swabs from primary or secondary syphilis lesions (n = 231), and only a minority were whole blood or tissue samples (n = 50). Swab samples from patients with rapid plasma regain (RPR) values of 1-1024 were more frequently PCR-positive (84.6%) compared to samples from patients with non-reactive RPR test (46.5%; p-value = 0.0001). Out of 281 typeable samples, 136 were fully-typed at all TP0136, TP0548, and TP0705 loci. Among the fully and partially typed samples, 25 different allelic profiles were identified. Altogether, eight novel allelic variants were found among fully (n = 5) and partially (n = 3) typed samples. The distribution of TPA allelic profiles identified in the Czech Republic from 2004 to 2017 revealed a dynamic character with allelic profiles disappearing and emerging over time. While the number of samples with the A2058G mutation was seen to increase (86.7% in 2016/2017), the number of samples harboring the A2059G mutation was found to have decreased over time (3.3% in 2016/2017). In addition, we found several allelic profile associations with macrolide resistance or susceptibility, the gender of patients, as well as patient residence.

Indexed as

Multilocus Sequence TypingAdultAllelesAnti-Bacterial AgentsCzech RepublicDNA, BacterialDrug Resistance, BacterialFemaleGenotypeHumansMaleRNA, Ribosomal, 23SSyphilisTreponema pallidumYoung AdultAnti-Bacterial AgentsDNA, BacterialRNA, Ribosomal, 23S

Identifiers

PMID31150464
PMCPMC6544256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.